Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.10% | 171.56 | 1.3% | $500.63m | |
| BIIB | Biogen Inc. | 1.48% | 236.36 | 1.3% | $486.35m | |
| CELG | Celgene Corporation | 0.22% | 96.46 | 1.3% | $469.64m | |
| GILD | Gilead Sciences, Inc. | 0.25% | 66.69 | 0.9% | $453.31m | |
| ILMN | Illumina, Inc. | 2.17% | 313.12 | 3.5% | $316.51m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.94% | 319.07 | 2.6% | $292.87m | |
| A | Agilent Technologies, Inc. | -0.18% | 68.20 | 1.6% | $199.60m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.68% | 173.65 | 1.9% | $182.34m | |
| EXAS | Exact Sciences Corporation | -1.38% | 95.61 | 25.3% | $168.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 128.01 | 2.0% | $150.52m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.89% | 88.25 | 4.3% | $118.75m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.94% | 122.33 | 14.7% | $116.57m | |
| INCY | Incyte Corporation | 0.89% | 79.38 | 2.5% | $107.69m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.95% | 68.58 | 8.2% | $98.40m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.90% | 68.48 | 9.2% | $96.47m |
Company Profile
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.